<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<meta content="text/html;charset=ISO-8859-1" http-equiv="Content-Type">
</head>
<body bgcolor="#ffffcc" text="#000000">
<meta content="text/html;charset=ISO-8859-1" http-equiv="Content-Type">
<meta content="text/html;charset=ISO-8859-1" http-equiv="Content-Type">
<meta content="text/html;charset=ISO-8859-1" http-equiv="Content-Type">
<br>
<meta content="text/html;charset=ISO-8859-1" http-equiv="Content-Type">
<meta content="text/html;charset=ISO-8859-1" http-equiv="Content-Type">
<img alt="" src="cid:part1.03090502.03030805@pfli.org" height="137"
width="887"><br>
<font color="#3333ff"><b><big><big><font face="Calisto MT">PharmFacts
E-News Update -- 23 Sept 2009 AD<br>
</font></big></big></b></font><span
style="font-size: 10pt; font-family: arial;"><font size="3"><font
color="#990000"><strong>This daily e-newsletter is only possible
through the generous gifts of our readers and supporters. Please help
us continue to fight for the defense of babies by donating
today!</strong></font><strong> </strong><a moz-do-not-send="true"
href="http://www.pfli.org/shop/index1.html"><strong>Click
here</strong></a><strong><a moz-do-not-send="true"
href="http://www.pfli.org/shop/index1.html">
</a><font color="#990000">to
help.</font></strong></font></span><br>
<font color="#3333ff"><big><big><font face="Calisto MT"><small><small><font
color="#000000"></font></small></small></font></big></big></font><br>
<font face="Verdana" size="2"><font face="Verdana" size="2"><tt><b><i><u><img
src="cid:part2.03060109.05060801@pfli.org" height="212" width="284"><br>
<big><big><a href="http://pharmphun.blogspot.com/2009/09/hilarious.html">
ObamaCare Pace Car revealed at Tea Party...</a>
<br>
<br>
</big></big></u></i></b></tt></font></font><font face="Verdana" size="2"><font
face="Verdana" size="2"><tt><font color="#ff0000"><font
face="Calisto MT, serif"><font face="ARIAL, VERDANA, HELVETICA"><font
size="6"><b><i><u><a
href="http://www.christiannewswire.com/news/5519911600.html"><b><i><u><font
size="+1">NO UNETHICAL LINES IN 4 NEW H1N1 VACCINES APPROVED...</font></u></i></b></a><b><i><u><font
size="+1"><br>
<a
href="http://www.google.com/url?sa=X&q=http://www.bismarcktribune.com/news/opinion/letters/article_3e7e9e96-a623-11de-87bf-001cc4c002e0.html&ct=ga&cd=zqUq3HMj42k&usg=AFQjCNEiBINn82PwRjxIcSNDV0_Sopa4IQ">
NEWS FOR PREBORN GRIM...</a>
<br>
<a
href="http://www.operationrescue.org/archives/another-ex-abortion-worker-comes-forward-to-allege-illegal-acts-by-carhart/">
Another Carhart ex-employee becomes whistle blower; case for
indictments grows...</a></font></u></i></b></u></i></b></font></font></font></font></tt></font></font><br>
<span style="font-size: 10pt; font-family: arial;">
<p style="font-weight: bold;" align="center"><font size="6"><span
style="font-size: 10pt; font-family: arial;"></span></font></p>
</span>
<hr size="2" width="100%"><span
style="font-size: 10pt; font-family: arial;">
<p style="font-weight: bold;" align="center"><font size="6"><span
style="font-size: 10pt; font-family: arial;"><small><font size="6"><small>HUMAN
RIGHT</small></font></small><font size="6"><small>S CAMPAIGN SEEKS
PERSONHOOD 2010 AMENDMENT TO CA
CONSTITUTION; 6th STATE</small><br>
</font></span></font></p>
<p><strong>SACRAMENTO, CA (for 28 September 2009)</strong>
<br>
<br>
<span style="font-weight: bold;">WHAT:</span> A press
conference announcing submission of the California Human Rights
Amendment,
a proposed 2010 California ballot initiative.<br>
<br>
The California Civil
Rights Foundation will submit language to California Attorney General
Jerry
Brown for a Human Rights Amendment recognizing the personhood of every
human being from the beginning of the biological development of that
human
being.<br>
<br>
Founded by Walter Hoye, the California Civil Rights
Foundation works to recognize the personhood rights of every human
being.<br>
<br>
<span style="font-weight: bold;">WHEN: </span>Monday,
Sep.28 2009, 11 a.m.<br>
<br>
<span style="font-weight: bold;">WHERE:
</span>The Office of the Attorney General, 1300 I Street, Sacramento,
CA
95814<br>
<br>
<span style="font-weight: bold;">WHO:</span><br>
- Walter
Hoye, sponsor of the California Human Rights Amendment and founder of
California Civil Rights Foundation<br>
- Judie Brown president of American
Life League<br>
- Lila Rose, president of Live Action and co-sponsor of the
California Human Rights Amendment<br>
<br>
<span style="font-weight: bold;">WHY:</span><br>
"It is clear the only way to heal our land and
restore the Founders’ vision is to rec­og­nize human per­son­hood as
a fun­da­men­tal and Con­sti­tu­tional right," Judie Brown said. "The
mis­sion of the California Human Rights Amendment is sim­ple, the
mes­sage direct and the result will be a pro­found return to the value
that shaped our civ­i­liza­tion. It is always the right time to fight
for justice."<br>
<br>
“The California Civil Rights Foundation recognizes
the inherent human rights, dignity and worth of all human beings from
the
beginning of their biological development,” stated Hoye. “If passed,
this historic legislation would make California the first state in the
Union to acknowledge full human rights for every human being. We
believe
all human beings should be protected by love and by law.”<br>
<br style="font-weight: bold;">
<span style="font-weight: bold;">The California
Human Rights Amendment to the Constitution of California:</span><br
style="font-weight: bold;">
<br>
Article 1, Section 7<br>
</p>
<blockquote style="font-style: italic;">(c)“The term "person" applies
to all living
human beings from the beginning of their biological development --
regardless of the means by which they were procreated, method of
reproduction, age, race, sex, gender, physical well-being, function, or
condition of physical or mental dependency and/or
disability.</blockquote>
<p><strong>California Human Rights
Amendment:</strong></p>
<p><a moz-do-not-send="true"
href="http://ss.all.org/link.php?M=84895&N=389&L=2785&F=H">http://californiahumanrightsamendment.com/
</a></p>
<p align="left"><strong>PersonhoodUSA:</strong> <br>
<a moz-do-not-send="true"
href="http://ss.all.org/link.php?M=84895&N=389&L=1704&F=H">http://www.personhoodusa.com/
</a></p>
<p align="left"><span style="font-weight: bold;">American Life
League</span><strong>:</strong> Personhood <br>
<a moz-do-not-send="true"
href="http://ss.all.org/link.php?M=84895&N=389&L=1703&F=H">http://all.org/personhood/</a><br>
</p>
<br>
</span>
<hr size="2" width="100%">
<div class="moz-text-html" lang="x-unicode"><font id="role_document"
color="#000000" face="Arial" size="2"> </font>
<div><font id="role_document" color="#000000" face="Arial" size="2">[[<b>FYI
</b>-- Note that this article about new "infertility treatments" using <em>asexual
methods of human reproduction</em> was written over a year ago, and
represents only a partial list of the research studies listed just on
PubMed at the time. By now the total number of such
"infertility" research studies performed in IVF and other ART clinics <em>and
their research laboratories</em> has multiplied exponentially. As
noted, the animal studies on "infertility treatments" performed before
moving to human patients is well underway, and as noted asexually
reproduced experimental human embryos are already being implanted into
women as "infertility treatments". But unless one knows the various
dubious "terms" so cleverly used in such searches (e.g., "reconstructed
oocyte", "hemi-cloning", "embryo multiplication", etc.) they are
admittedly difficult to find. Needless to say, many of these implanted
asexually reproduced embryos spontaneously abort; but many of them
don't. <strong>The issues of abortion and human embryo research and
human cloning are no longer separate issues</strong>. <strong>The
issues of "sexual reproduction" and "asexual reproduction" are no
longer separate issues.</strong> This is an empirical fact, not a
subjective opinion. It is not a wonder, then, that lobbyists,
politicians, drug companies and scientists representing the IVF and ART
industries have been so successful in getting blatantly false
scientific terms in so many legal bills and regulations in order to
create legal loopholes for their industries. Check it out yourself.
-- <b>DNI]</b>]</font></div>
<div><font id="role_document" color="#000000" face="Arial" size="2"> </font></div>
<div><font id="role_document" color="#000000" face="Arial" size="2"> </font></div>
<div>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"><a class="moz-txt-link-freetext" href="http://www.lifeissues.net/writers/irv/irv_130reproductivecloning.html">http://www.lifeissues.net/writers/irv/irv_130reproductivecloning.html</a></font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Dianne N. Irving, M.A., Ph.D.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">copyright July 18, 2008</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">[Note:<span style=""> </span>This
article is copyrighted and thus must be acknowledged when using its
original ideas and resources or quoting from it.]</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><o:p><font id="role_document" color="#000000"
face="Arial" size="2"><font face="Times New Roman" size="3"> </font></font></o:p></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><span
style="color: black; font-size: 20pt;"><font face="Times New Roman">So
You Think That “Reproductive Cloning” Isn’t Done Yet?<span style=""> </span>Guess
Again<o:p></o:p></font></span></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><o:p><font id="role_document" color="#000000"
face="Arial" size="2"><font face="Times New Roman" size="3"> </font></font></o:p></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><span
style="color: black; font-size: 16pt;"><font face="Times New Roman">I.<span
style=""> </span>Introduction<o:p></o:p></font></span></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><o:p><font id="role_document" color="#000000"
face="Arial" size="2"><font face="Times New Roman" size="3"> </font></font></o:p></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><font id="role_document" color="#000000"
face="Arial" size="2"><font size="3"><font face="Times New Roman">In
the article, “The future of fertility” [Jeremy Laurance,
Independent.co.uk, July 17, 2008] -- copied in full below -- the
researchers and IVF specialists claim that “reproductive cloning” is an
exciting if not still a far off possibility – implying that it has yet
to be done.<o:p></o:p></font></font></font></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><o:p><font id="role_document" color="#000000"
face="Arial" size="2"><font face="Times New Roman" size="3"> </font></font></o:p></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><font id="role_document" color="#000000"
face="Arial" size="2"><font size="3"><font face="Times New Roman"><b>Wrong.<span
style=""> </span>Guess again.</b><o:p></o:p></font></font></font></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><o:p><font id="role_document" color="#000000"
face="Arial" size="2"><font face="Times New Roman" size="3"> </font></font></o:p></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><font id="role_document" color="#000000"
face="Arial" size="2"><font size="3"><font face="Times New Roman">But
don’t take my word for it.<span style=""> </span>Check it out for
yourself.<span style=""> </span>All one has to do to realize this is
scan the list of scientific and medical references provided here below
(the tip of the iceberg) that document the fact that <b>all sorts of
reproductive cloning has been going on for a long time.</b><span
style=""><b> </b> </span><o:p></o:p></font></font></font></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><o:p><font id="role_document" color="#000000"
face="Arial" size="2"><font face="Times New Roman" size="3"> </font></font></o:p></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><span
style="color: black; font-size: 16pt;"><font face="Times New Roman">II.<span
style=""> </span>“Abortion” now involves asexually reproduced human
embryos<o:p></o:p></font></span></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><o:p><font id="role_document" color="#000000"
face="Arial" size="2"><font face="Times New Roman" size="3"> </font></font></o:p></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><font id="role_document" color="#000000"
face="Arial" size="2"><font size="3"><font face="Times New Roman">In
case it hasn’t occurred to people, once cloned and other asexually
reproduced human embryos are implanted into a woman’s uterus, then the
“abortion” issue looms large, especially given that such “infertility
treatments” are still rather experimental (not sure what will happen,
either to the embryo or later fetus or the woman).<span style=""> </span>“Prolife”
no longer has the luxury of considering and protecting only sexually
reproduced human beings <i style="">in vivo</i>.<o:p></o:p></font></font></font></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="color: black;"><o:p><font id="role_document" color="#000000"
face="Arial" size="2"><font face="Times New Roman" size="3"> </font></font></o:p></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font size="3"><font
face="Times New Roman"><span style="color: black;">For starters, </span>extensive
human cloning, and other forms of human genetic engineering -- <strong><span
style="font-weight: normal;">all of which can asexually reproduce new
living single-cell human organisms (human beings)</span></strong> --
are already being done in IVF clinics, for both "research" and for
"reproductive" purposes. <span style=""> </span>One of the most
common IVF techniques is called “twinning” – and twinning is one of
many different kinds of <i style="">cloning techniques</i>.<span
style=""> </span>The procedure mimics the kind of identical twinning
that takes place naturally inside the fallopian tube of a women,
resulting in the asexual reproduction of an identical twin, triplet,
etc.<span style=""> </span>This long-used “infertility treatment”
involves implanting the resulting twins/triplets into a woman’s uterus,
and bringing them to birth.<span style=""> </span>Along with using
the “twinning” cloning technique, IVF centers also use several other
human cloning techniques to asexually reproduce new living human
embryos which are likewise implanted and brought to birth.</font></font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Below are just two published research
studies documenting (1) the various kinds of human cloning techniques
available to IVF "clinics", and (2) an example of how it is
already being done:</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"> </font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">#1. Note that various cloning
techniques have already been developed in animal work for over 25
years, and are applicable to cloning human beings. Here <strong><span
style="font-weight: normal;">several human cloning techniques</span></strong>
are mentioned, including "hemicloning", "nuclear transfer", and "embryo
splitting" (twinning – also called “blastomere separation, blastocyst
splitting, embryo multiplication, etc.):</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"> </font></p>
<p style="margin: 0in 0in 0pt 0.5in;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman"><b><font size="3">New techniques on embryo
manipulation</font></b><b><span style="font-size: 10pt;">.</span></b></font><font
size="3"><font face="Times New Roman"><span style=""> </span><span
style="">Escriba MJ, Valbuena D, Remohi J, Pellicer A, Simon C.<span
style=""> </span>(Spain)</span><br>
For many years, experience has been accumulated on embryo and gamete
manipulation in livestock animals. <strong><span
style="font-weight: normal;">The present work is a review of these
techniques and </span>their possible application in human embryology</strong><strong><span
style="font-weight: normal;"> in specific cases</span></strong>. It is
possible to <strong>manipulate gametes</strong> at different levels,
producing <strong>paternal or maternal haploid embryos (hemicloning)</strong>,
using different techniques including <strong>nuclear transfer.</strong>
At the embryonic stage, considering practical, ethical and legal
issues, <strong><span style="font-weight: normal;">techniques will be
reviewed that include </span>cloning and embryo splitting at the
cleavage stage, morula, or blastocyst stage</strong>.<span style=""> </span>[PubMed
Reference:<span style=""> </span>PMID: 12062830]</font></font></font></p>
<p style="margin: 0in 0in 0pt 0.5in;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"><a class="moz-txt-link-freetext" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12062830">http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12062830</a></font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"> </font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">#2. Note that <strong><span
style="font-weight: normal;">human cloning can be used for both
"research" and for "reproductive" purposes, e.g., for "infertility
treatments"</span></strong><b style="">.</b> In the study below, the
human <strong><span style="font-weight: normal;">oocytes</span></strong><b
style=""> </b>from <strong><span style="font-weight: normal;">infertility patients
in private IVF clinics</span></strong> were <strong><span
style="font-weight: normal;">cloned</span></strong><b style=""> </b>using
"nuclear transfer". Since the transfer was not done using a "somatic"
cell, it is not properly defined as "somatic cell nuclear transfer"
(SCNT), but rather as "germ line cell nuclear transfer" (GLCNT). Both
somatic cells and germ line cells (e.g., oocytes) are <strong><span
style="font-weight: normal;">diploid</span></strong>, therefore
nuclear transfer (cloning) can be accomplished using either type of
cell. The "product" is referred to below as a "reconstructed oocyte",
and it is "activated". That means that upon activation <strong><span
style="font-weight: normal;">a new genetically unique living human
being -- a single-cell human embryo -- has been reproduced by means of
human cloning using the GLCNT technique</span></strong><b style="">.</b>
The term "reconstructed oocyte" is a euphemism, or "pre-embryo
substitute" for the single-cell <strong><span
style="font-weight: normal;">human organism</span></strong> formed by
cloning. It is not just an "oocyte" any more. It is a single-cell
human being. I question how the <strong><span
style="font-weight: normal;">"informed consent"</span></strong> forms
phrased it so that these infertility patients understood clearly and
unambiguously that their diploid oocytes had been used to asexually
reproduce their own cloned children?</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt 0.5in;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Fertil Steril. 2003 Mar;79 Suppl
1:677-81</font></font></p>
<p style="margin: 0in 0in 0pt 0.5in;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font size="3"><font
face="Times New Roman"><strong>Microfilament disruption is required
for enucleation and nuclear transfer in germinal vesicle but not
metaphase II human oocytes</strong><strong><span
style="font-weight: normal;">.</span></strong></font></font><b><br>
</b><font face="Times New Roman" size="3">Tesarik J, Martinez F, Rienzi
L, Ubaldi F, Iacobelli M, Mendoza C, Greco E. (Spain)<br>
OBJECTIVE: To evaluate the usefulness of microfilament disruption <strong><span
style="font-weight: normal;">before enucleation and nuclear transfer
in human oocytes at different stages of maturation</span></strong>.
DESIGN: Prospective experimental study. SETTING: <strong><span
style="font-weight: normal;">Private clinics. PATIENT(S): Infertile
couples undergoing assisted reproduction attempts.</span></strong>
INTERVENTION(S): Oocyte enucleation and nuclear transfer, <strong><span
style="font-weight: normal;">activation of reconstructed oocytes.</span></strong>
CONCLUSION(S): Microfilament disruption before enucleation is required
for germinal vesicle oocytes but not for metaphase II oocytes.<span
style=""> </span>[PubMed Reference:<span style=""> </span>PMID:
12620476]</font></font></p>
<p style="margin: 0in 0in 0pt 0.5in;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"><a class="moz-txt-link-freetext" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12620476">http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12620476</a></font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Indeed infertility researchers are
eager to use any and all cloning techniques for infertility
“therapies”, and thus they attempt to limit the damage of any pending
cloning legislation by narrowing the definition of “cloning” to just
SCNT.<span style=""> </span>As admitted recently by Dr. Jamie Grifo,
a leading infertility researcher at New York University:</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt 0.5in;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font size="3"><font
face="Times New Roman"><span style="">“Infertility researchers take
pains to </span>define cloning in the narrowest terms, as a process
that would use the nucleus from a single mature cell and place it in a
woman's egg from which the nucleus had been removed - then jolting that
hybrid cell to life with electricity.<span style=""> </span>No sperm
need be involved, so the baby's genetic material would all come from
just one person.<span style=""> </span>While many infertility
specialists recoil at the prospect of such ‘solo’ cloning, there are
critical aspects of the process that could help infertile couples. A
number of infertility programs across the country are working on
treatments that might be called ‘near-cloning’.</font></font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">[Doctor Jamie Grifo, a leading
infertility researcher at New York University, as quoted in Stephen
Smith,<span style=""> </span>“Cloning bans could have impact on
infertility treatments”, Jan. 9, 1998, at
<a class="moz-txt-link-freetext" href="http://www.geometry.net/detail/basic_i/infertility_family_science_page_no_3.html">http://www.geometry.net/detail/basic_i/infertility_family_science_page_no_3.html</a>.]</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"> </font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Thus as Weissman redefines SCNT as
just “stem cell research”, many infertility researchers <i style="">redefine
all cloning techniques as just “infertility treatments”</i> involving
“near-cloning”!<span style=""> </span>We are <i style="">clearly</i>
talking about <i style="">“reproductive cloning”</i> here, not just
“infertility treatments”.<span style=""> </span>Hello? </font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><span
style="font-family: 'Arial','sans-serif'; font-size: 10pt;"><font
id="role_document" color="#000000" face="Arial" size="2"> <o:p></o:p></font></span></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman"><font size="3">For a 31-page list of similar
experiments already published and recorded on PubMed, please see:
Irving, “Scientific References, Human Genetic Engineering (Including
Cloning):<span style=""> </span>Artificial Human Embryos, Oocytes,
Sperms, Chromosomes and Genes”<b style=""> </b>(May 25, 2004), at:
<a class="moz-txt-link-freetext" href="http://www.lifeissues.net/writers/irv/irv_25scientificrefer1.html">http://www.lifeissues.net/writers/irv/irv_25scientificrefer1.html</a></font><span
style="font-size: 10pt;">.</span></font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><span
style="font-size: 16pt;"><font face="Times New Roman">III.<span
style=""> </span><i style="">Partial</i> list of IVF researchers
doing reproductive cloning, and examples of organizations whose
policies support them<o:p></o:p></font></span></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Take a long hard look:</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>M.J.
Escribá, D. Valbuena, J. Remohí, et al., “New Techniques on Embryo
Manipulation,” <i style="">American Journal of Reproductive Immunology</i>
55, no 1 (May–June 2002): 149–161, available from
<a class="moz-txt-link-freetext" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12062830">http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12062830</a>.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>J.W. Gordon
and F.H. Ruddle, “Integration and Stable Germ Line Transmission of
Genes Injected Into Mouse Pronuclei,” <i style="">Science </i><span
style=""> </span>214, no. 4526 (December 11, 1981): 1244–1246.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>J. Hao,
J. Pareja, N. Zaninovic, “P–1022: Derivation of Embryonic Stem Cells
>From Individual 2-Cell Mouse Embryos: Model for Blastomere Totipotency
and Embryo Splitting,” <i style="">Fertility and Sterility</i> 86, no.
3 (September 2006): S513.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Erik Parens
and Lori P. Knowles, “Reprogenetics and Public Policy: Reflections and
Recommendations,” <i style="">The Hastings Center Report </i>(HCR)
Special supplement (July 1, 2003), available from
<a class="moz-txt-link-freetext" href="http://www.thehastingscenter.org/research/reprogenetics-public-policy.asp">http://www.thehastingscenter.org/research/reprogenetics-public-policy.asp</a>.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Karl Illmensee,
Khalied Kaskar, and Panayiotis M. Zavos, “<i style="">In Vitro</i>
Blastocyst Development From Serially Split Mouse Embryos and Future
Implications for Human Assisted Reproductive Technologies,” <i style="">Fertility
and Sterility</i>, 86, no. 4 (September 7, 2006a): 1112–1120, available
from <a class="moz-txt-link-freetext" href="http://www.fertstert.org/article/PIIS0015028206010776/abstract">http://www.fertstert.org/article/PIIS0015028206010776/abstract</a>.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Karl Illmensee,
Mike Levanduski, and Panayiotis M. Zavos, “Evaluation of the Embryonic
Preimplantation Potential of Human Adult Somatic Cells Via an Embryo
Interspecies Bioassay Using Bovine Oocytes,” Fertility and Sterility 85
(April 2006b): 1248–1260, available from
<a class="moz-txt-link-freetext" href="http://www.fertstert.org/article/PIIS0015028205042032/abstract">http://www.fertstert.org/article/PIIS0015028205042032/abstract</a>.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Y. Katagiri,
T. Takeuchi, Q.V. Neri, et al., “Imprinted Gene Expression in Cloned
Blastocysts,” <i style="">Fertility and Sterility</i> 82 (September
2004): S10.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Yoko Kato,
W.M. Rideout, K. Hilton, et al., “Developmental Potential of Mouse
Primordial Germ Cells,” <i style="">Development </i>126, no. 9
(January 5, 1999): 1823–1832.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>A. Liu,
“Human Embryo Cloning Prohibited in Hong Kong,” <i style="">Journal of
Assisted Reproductive Genetics </i>22, no. 11–12 (December 2005):
369–378, available from PubMed #16331533.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>H.C.C. Liu,
Z.Y. He, and Z. Rosenwaks, “Ovarian Tissue Cryopreservation Did Not
Compromise Its Potential to Produce Competent Oocytes for Nuclear
Transfer,” <i style="">Fertility and Sterility</i> 82 (September
2004): S308.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>H. Liu,
Z. He, W. Wang, et al., “Demiembryo Viability Can Be Improved by
Symmetric Embryo Splitting,” <i style="">Fertility and Sterility</i>
84 (September 2005a): S368.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>H. Liu,
Z. He, W. Wang, and Z. Rosenwaks, “Strategies for Monozygotic Twinning
by Embryo Splitting,” <i style="">Fertility and Sterility</i> 84
(September 2005b): S370.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Q.V. Neri
et al., “Genomic Expressions in the Cloned Blastocyst,” <i style="">Fertility
and Sterility</i> 82 (September 2004): S281.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Q.V. Neri
et al., “Devising a Method to Reprogram Somatic Nuclei for Nuclear
Transplantation Procedures,” <i style="">Fertility and Sterility</i>
84 (September 2005): S400–401.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Q.V. Neri
et al., “Gene Expression in ESCs Derived from Cloned Blastocytes,” <i
style="">Fertility and Sterility</i> 84 (September 2005): S384.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Laura A.
Schieve, Sonja A. Rasmussen, Germaine M. Buck, et al., “Are Children
Born after Assisted Reproductive Technology at Increased Risk for
Adverse Health Outcomes?” <i style="">Obstetrics and Gynecology</i>
103, no. 6, (June 2004): 1154–1163, available from PubMed #15172847.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>J. Tesarik,
F. Martinez, L. Rienzi, et al., “Microfilament Disruption Is Required
for Enucleation and Nuclear Transfer in Germinal Vesicle But Not
Metaphase II Human Oocytes,” <i style="">Fertility and Sterility</i>
79, Supplement 1 (March 2003): 677–681, available from PubMed #
12620476.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>M.C.
Valiotis, O. Lacham-Kaplan and A.O. Trounson, “Pronuclei Formation and
Embryo Cleavage Following Electrofusion of Round Spermatids with
Oocytes from the Mouse,” <i style="">Proceedings of the Australian
Society for Reproductive Biology</i> 25, (1993): 48.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Institute
of Medicine and National Research Council, Committee on the Basic
Science Foundations of Medically Assisted Conception, <i style="">Report
of a Study and Workshop Papers, “Medically Assisted Conception: An
Agenda for Research,”</i> (1989), available from
<a class="moz-txt-link-freetext" href="http://www.nap.edu/catalog.php?record_id=1433">http://www.nap.edu/catalog.php?record_id=1433</a>.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>National
Academy of Sciences, Committee on Science, Engineering, and Public
Policy, <i style="">Scientific and Medical Aspects of Human
Reproductive Cloning: How Is Reproductive Cloning Done?</i> (2002b),
available from <a class="moz-txt-link-freetext" href="http://books.nap.edu/books/0309076374/html/25.html">http://books.nap.edu/books/0309076374/html/25.html</a>.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">-- American Fertility Society, Ethics
Committee, “Ethical Considerations of the New Reproductive
Technologies,” <i style="">Fertility and Sterility</i> 46, Supplement
1 (September1986): 27S, (name changed to American Society of
Reproductive Medicine in 1990s; still publish their scientific journal,
<i style="">Fertility and Sterility</i>; chairs of ethics committees
included Richard McCormick, S.J. and Clifford Grobstein).</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>American
Medical Association, Council on Ethical and Judicial Affairs, <i
style="">CEJA Report </i>1–I–94, “Pre–Embryo Splitting” (1994),
available from
<a class="moz-txt-link-freetext" href="http://www.ama-assn.org/apps/pf_new/pf_online?f_n=browse&doc=policyfiles/HnE/E-2.145.HTM">http://www.ama-assn.org/apps/pf_new/pf_online?f_n=browse&doc=policyfiles/HnE/E-2.145.HTM</a>;
Endorses “pre-embryo splittting” as infertility treatment.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>American
Society of Reproductive Medicine, Ethics Committee Report, “Human
Somatic Cell Nuclear Transfer,” <i style="">Fertility and Sterility</i>
74, no. 5 (November 2000): 873–876, available from
<a class="moz-txt-link-freetext" href="http://www.asrm.org/Media/Ethics/cloning.pdf">http://www.asrm.org/Media/Ethics/cloning.pdf</a>.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>American
Society for Reproductive Medicine, Ethics Committee, “Embryo Splitting
for Infertility Treatment,” <i style="">Fertility and Sterility</i>
82, Supplement 1 (September 2004): S256–7, available from PubMed
#15363746.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>German
National Ethics Council, <i style="">Cloning for Reproductive Purposes
and Cloning for the Purposes of Biomedical Research</i> (Berlin 2004),
available from
<a class="moz-txt-link-freetext" href="http://www.ethikrat.org/_english/publications/Opinion_Cloning.pdf">http://www.ethikrat.org/_english/publications/Opinion_Cloning.pdf</a>.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">--<span style=""> </span>Tremane
Barr, “Analysis of the New Zealand Government’s Proposals to Amend the
Human Assisted Reproductive Technology Bill” (2003), available from
<a class="moz-txt-link-freetext" href="http://www.gefree.org.nz/cloning.htm">http://www.gefree.org.nz/cloning.htm</a>.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> *************************************************************</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"> </font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"><a class="moz-txt-link-freetext" href="http://www.independent.co.uk/life-style/health-and-wellbeing/health-news/the-future-of-fertility-869729.html">http://www.independent.co.uk/life-style/health-and-wellbeing/health-news/the-future-of-fertility-869729.html</a></font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"> </font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Independent.co.uk</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">July 17, 2008</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">See <a class="moz-txt-link-abbreviated" href="http://www.nature.com">www.nature.com</a></font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><span
style="font-size: 22pt;"><font face="Times New Roman">The future of
fertility<o:p></o:p></font></span></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">100-year-old women giving birth; IVF
cycles available for £50; gestation in artificial wombs... it will all
be possible in the next 30 years, say the world's leading fertility
experts</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">By Jeremy Laurance<br>
Thursday, 17 July 2008 </font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Thirty years ago the birth of Louise
Brown, the world's first test-tube baby, marked a genuine medical
breakthrough – one of the few that deserves the title. Until then, the
limited treatments on offer – surgery and hormone therapy – could help
only some of the millions of infertile couples devastated by the
discovery that they were unable to create a family.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">On 25 July 1978 they learnt they had
another option that could deliver a baby – and a future. Early fears
about the safety and morality of the procedure were swept aside in the
rush to take advantage of it. Today, some four million babies have been
born by IVF worldwide. In Britain it is estimated that every primary
school has at least one IVF child. </font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Yet as quickly as it has solved
problems, the new science of fertility has created them. No area of
medicine has seen more spectacular advances, but no area has thrown up
more ethical conundrums.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">At the time of Louise Brown's birth,
doctors were able to treat barely half of the infertile couples – one
in seven of the population – who came to them for help. Surgery for
blocked fallopian tubes and hormone treatment to stimulate egg
production were the only available treatments for women. There was
nothing available for men. </font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Today, in a special report published
by the journal Nature, scientists make some extraordinary predictions
about the future of fertility treatment. They forecast an end to
infertility with the potential for any person of any age from one to
100 to have children. In place of a normal pregnancy, gestation might
take place in an artificial womb, with embryos selected and genetically
manipulated to ensure they were free of disease. </font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Low-cost IVF might be made available
at £50 a cycle, putting it in reach of some parts of the developing
world. Cloned babies, though banned in this country and many others,
are likely to become a reality, scientists say. </font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Thirty years ago these claims would
have been treated as science fiction. Today they seem entirely
realistic, beside the advances we have already seen. Who would have
predicted in 1978 that male infertility would be successfully treated
by injecting individual sperm directly into the egg? The technique,
known as intra cytoplasmic sperm injection (ICSI), first introduced in
1992, is now used in more than half of all IVF treatments in the UK. </font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Who would have predicted that embryos
would be selected, by sex or by genetic markers for almost 200 diseases
using the technique of pre-implantation diagnosis, so that only healthy
ones were replaced in the womb?</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Today we have saviour siblings (babies
created to provide a sick older sibling with matching tissue) and
animal-human hybrids (created by placing human cell nuclei into the
eggs of cows or rabbits to create embryos that are 99 per cent human
and are used for research up to 14 days – because of the shortage of
human eggs). </font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">The most exciting area is stem-cell
research using embryos – and ordinary adult skin cells treated to
behave like embryonic stem cells, called induced pluripotent stem cells
(iPS) – from which it is hoped new tissue can be grown for the
treatment of conditions including Alzheimer's , Parkinson's and similar
conditions. </font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">This is the new scientific frontier on
which, 30 years on from Louise Brown's birth, researchers now stand.
Work on embryos which was exclusively focused on developing new
treatments for infertility has now expanded to include the search for
cures for disease. With an updated Bill due to be passed into law later
this year, which gives legal sanction to these techniques, the stage is
set for further advance – and further controversy.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">(See <a class="moz-txt-link-abbreviated" href="http://www.nature.com">www.nature.com</a>)</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><span
style="font-size: 14pt;"><font face="Times New Roman">Looking ahead:
how the news may be made<o:p></o:p></font></span></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><font
size="3"><font face="Times New Roman">100-year-old gives birth<o:p></o:p></font></font></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Davor Solter, a developmental
biologist at the Institute of Medical Biology in Singapore </font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">I think IVF has gone about as far as
it can. Next I expect that germ cells – sperm and eggs – will be
derived from induced pluripotent stem (iPS) cells [cells that have the
potential to develop into any of the body's cell types]. It will be
possible to make iPS cells from skin cells, to make germ cells from
these, and then combine them to make human embryos. It means every
person, regardless of age, will be able to have children: newborn
children could have children and 100-year-olds could have children. It
could easily happen in the next 30 years. I have no idea if the
technique will be used, but it means you could have millions of gametes
that could be combined at will. I have no idea what kind of moral value
or rights we would give to those embryos. We'll probably go through the
same agonising we did with IVF. It could be terrible to begin with, but
then it'll become a fact of life. Maybe 20 to 30 years from now we'll
read that someone made 20,000 embryos and studied their development,
and we'll decide it's OK.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><font
size="3"><font face="Times New Roman">Cost of IVF falls to £50<o:p></o:p></font></font></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Alan Trounson, an IVF pioneer and
director of the California Institute for Regenerative Medicine in San
Francisco</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">IVF was a gigantic step. We didn't
realise it at the time; people didn't think it would work that well. We
never envisaged that it would expand so dramatically around the world.
Ethics keeps moving. What was once seen as dangerous goes on to be seen
as within the confines of acceptable risk. Probably the major
development in the field will come from something we've never thought
about. I think there will be a further expansion of low-cost IVF,
especially for women in developing countries who experience social
discrimination with infertility. If you remove all the expensive stuff
and use low-cost drugs (such as clomiphene) and remove just one or two
eggs, and only transfer one embryo, it can be done for less than US$100
(£50).</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><font
size="3"><font face="Times New Roman">First cloned baby born<o:p></o:p></font></font></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Miodrag Stojkovic, stem-cell biologist
at the Prince Philip Centre of Investigation in Valencia, Spain</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Will we see a cloned baby? It could
happen any day because of a lack of regulation [in some countries].
People are already trying to do reproductive cloning. The only problem
is getting hold of enough viable human oocytes [eggs]. If we can make
human oocytes from stem cells, it might be easier. There is no medical
need to clone a human. The future is not about reproductive cloning,
that's a very, very detrimental technique.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><font
size="3"><font face="Times New Roman">The artificial womb<o:p></o:p></font></font></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Scott Gelfand, director of the Ethics
Centre at Oklahoma State University in Stillwater</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">There is some research aiming to
increase embryo survival. There are also people who are working on the
other end – at the moment babies can only survive from about 22 weeks.
Someone could join these two advances together and we could have
complete ectogenesis [in which the foetus develops outside the body in
an artificial uterus]. I find it interesting – and scary. Even in terms
of insurance: if it became economically competitive with other forms of
gestation, insurers might compel a person to use it to avoid premature
birth or foetal alcohol syndrome. It's something that really needs to
be talked about. Will it happen? Dolly was a complete surprise to
everybody...</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><font
size="3"><font face="Times New Roman">Parents can choose favourite
embryo<o:p></o:p></font></font></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Susannah Baruch, director of
reproductive genetics at the Genetics and Public Policy Centre at Johns
Hopkins University in Washington DC</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">There's speculation that people will
have designer babies, but I don't think the data is there to support
that. No single gene predicts blondness or thinness or height or
whatever the 'perfect baby' looks like. You might find genetic
contributors, but there are so many environmental factors too. More
likely is that you'll have a set of embryos and you'll know every
single thing about every gene in every embryo. For example, one embryo
will have three genes associated with tallness, two for weakness, three
for poor vision and some for disease; and the second embryo will have
some other set. None of us is a perfect specimen and none of our
embryos will be, either. I think you'll end up with a lot of
information but it's less obvious how useful that information will be
and how many parents will want it. Will people choose IVF to get that
genetic option? The old-fashioned way is cheaper and more fun and that
won't change in 30 years.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><b style=""><font
size="3"><font face="Times New Roman">Infertility is history<o:p></o:p></font></font></b></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">Zev Rosenwaks, director of the Centre
for Reproductive Medicine and Infertility in New York</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><o:p><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3"> </font></font></o:p></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"><font
face="Times New Roman" size="3">I see the technology going towards
possible eradication of infertility altogether. With nuclear-transfer
technology or cell modification, I think we'll be able to generate
sperm and eggs for anybody.</font></font></p>
<p style="margin: 0in 0in 0pt;" class="MsoNormal"><font
id="role_document" color="#000000" face="Arial" size="2"> </font></p>
</div>
</div>
<span style="font-size: 10pt; font-family: arial;"></span>
<hr size="2" width="100%"><font face="Calisto MT">PFLI
PharmAid Center<br>
<a moz-do-not-send="true" href="mailto:pfli@pfli.org">pfli@pfli.org</a><br>
PO Box 1281<br>
Powell, OH 43065-1281 USA</font><font face="Calisto MT"><br>
800-227-8359</font><font face="Calisto MT"><br>
<a moz-do-not-send="true" class="moz-txt-link-abbreviated"
href="http://www.pfli.org">www.pfli.org</a>
</font><br>
<p><a moz-do-not-send="true"
href="%3Cform%20action=%22https://www.paypal.com/cgi-bin/webscr%22%20method=%22post%22%3E,%3Cinput%20type=%22hidden%22%20name=%22cmd%22%20value=%22_s-xclick%22%3E,%3Cinput%20type=%22image%22%20src=%22https://www.paypal.com/en_US/i/btn/x-click-butcc-donate.gif%22%20border=%220%22%20name=%22submit%22%20alt=%22Make%20payments%20with%20PayPal%20-%20it%27s%20fast,%20free%20and%20secure%21%22%3E,%3Cinput%20type=%22hidden%22%20name=%22encrypted%22%20value=%22-----BEGIN%20PKCS7-----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
%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
VQQ%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-----END%20PKCS7-----,%22%3E,%3C/form%3E"><br>
<img alt="" src="cid:part3.02010804.06060206@pfli.org" height="44"
width="73"></a><br>
</p>
<p><font color="#3333ff"><big><big><font face="Calisto MT"><small><small><font
color="#000000">PFLI supports
pharmacist rights of conscience NOT
to be forced to dispense or counsel for chemicals which violate their
sincerely held religious, moral or ethical beliefs. For more info see:<br>
<a moz-do-not-send="true" class="moz-txt-link-freetext"
href="http://www.pfli.org/main.php?pfli=conscienceclausefaq">http://www.pfli.org/main.php?pfli=conscienceclausefaq</a></font></small></small></font></big></big></font></p>
<p><small>*** PFLI is the only pharmacy association which is
exclusively
pro-life.
<br>
It represents thousands of pharmacists and many lay supporters
<br>
in the USA, Canada and all around the globe. For membership info, key
<br>
PFLI texts, PFLI archives, late-breaking news, abridged newsletter
excerpts
<br>
or general information, visit the PFLI web site at <a
moz-do-not-send="true" href="http://www.pfli.org">http://www.pfli.org</a>.
<br>
Or e-mail us at <a moz-do-not-send="true" href="mailto:pfli@pfli.org">mailto:pfli@pfli.org</a>.
</small></p>
<p><small>*** We do NOT send out SPAM. To subscribe to PharmFacts
E-News, just send an e-mail
with the
word
<br>
"subscribe" in the subject area or better yet, just enroll right from
our main news page at<br>
<a moz-do-not-send="true" class="moz-txt-link-freetext"
href="http://www.pfli.org">http://www.pfli.org</a>; to cease your
subscription [although
we can't
<br>
imagine anyone would!] self-manage your account at:
<a moz-do-not-send="true" class="moz-txt-link-freetext"
href="http://pfli.org/mailman/listinfo/pflienews_pfli.org">http://pfli.org/mailman/listinfo/pflienews_pfli.org</a><br>
</small></p>
<p><small>*** You may contact PFLI at any/all of the following:
Pharmacists
For
Life International,
<br>
PO Box 1281, Powell, OH 43065-1281 USA, 1-800-227-8359 [US &
Canada only],
<br>
+1-740-881-5520 [voice] or +1-707-667-2447 [fax]; e-mail us at
<a moz-do-not-send="true" href="mailto:pfli@pfli.org">mailto:pfli@pfli.org</a>.
<br>
</small></p>
<p><small>*** You can order our publications as well as begin/renew
your
membership
or donate right on our
<br>
secure website at <a moz-do-not-send="true" href="http://www.pfli.org">http://www.pfli.org/shop</a>.
Click
on the "PFLI Store" link on the toolbar and
<br>
follow the prompts!
There you can also donate to PFLI as well as purchase a wide range of
publications. </small></p>
<font color="#3333ff"><b><big><big><font face="Calisto MT">
</font></big></big></b></font><br>
<br>
<div class="moz-signature">-- <br>
<img src="cid:part4.05020704.04030308@pfli.org" border="0"></div>
<br>
</body>
</html>